Free Trial
→ China ATTACK on American Dollar set for 11/12/2026 (From International Living) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aeon Global Health Corp stock logo
AGHC
Aeon Global Health
$0.00
$0.00
▼
$0.05
N/AN/AN/AN/A
Amarantus Bioscience Holdings Inc. stock logo
AMBS
Amarantus Bioscience
$0.00
$0.00
▼
$0.25
N/A1.74739,495 shsN/A
ARHCF
Alfresa
$14.00
$13.90
$14.00
▼
$14.59
N/AN/A2,750 shsN/A
CHCR
Advanzeon Solutions
$0.00
$0.00
▼
$0.00
N/AN/AN/AN/A
10 Best Stocks to Own in Fall 2026 Cover
10 Best Stocks to Own in Fall 2026

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aeon Global Health Corp stock logo
AGHC
Aeon Global Health
0.00%0.00%0.00%0.00%0.00%
Amarantus Bioscience Holdings Inc. stock logo
AMBS
Amarantus Bioscience
0.00%0.00%-99.96%-99.96%-66.67%
ARHCF
Alfresa
0.00%0.00%0.00%+17.94%+17.94%
CHCR
Advanzeon Solutions
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aeon Global Health Corp stock logo
AGHC
Aeon Global Health
$0.00
$0.00
▼
$0.05
N/AN/AN/AN/A
Amarantus Bioscience Holdings Inc. stock logo
AMBS
Amarantus Bioscience
$0.00
$0.00
▼
$0.25
N/A1.74739,495 shsN/A
ARHCF
Alfresa
$14.00
$13.90
$14.00
▼
$14.59
N/AN/A2,750 shsN/A
CHCR
Advanzeon Solutions
$0.00
$0.00
▼
$0.00
N/AN/AN/AN/A
10 Best Stocks to Own in Fall 2026 Cover
10 Best Stocks to Own in Fall 2026

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aeon Global Health Corp stock logo
AGHC
Aeon Global Health
0.00%0.00%0.00%0.00%0.00%
Amarantus Bioscience Holdings Inc. stock logo
AMBS
Amarantus Bioscience
0.00%0.00%-99.96%-99.96%-66.67%
ARHCF
Alfresa
0.00%0.00%0.00%+17.94%+17.94%
CHCR
Advanzeon Solutions
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aeon Global Health Corp stock logo
AGHC
Aeon Global Health
0.00
N/AN/AN/A
Amarantus Bioscience Holdings Inc. stock logo
AMBS
Amarantus Bioscience
0.00
N/AN/AN/A
ARHCF
Alfresa
0.00
N/AN/AN/A
CHCR
Advanzeon Solutions
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aeon Global Health Corp stock logo
AGHC
Aeon Global Health
N/AN/AN/AN/AN/AN/A
Amarantus Bioscience Holdings Inc. stock logo
AMBS
Amarantus Bioscience
N/AN/AN/AN/AN/AN/A
ARHCF
Alfresa
N/AN/AN/AN/AN/AN/A
CHCR
Advanzeon Solutions
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aeon Global Health Corp stock logo
AGHC
Aeon Global Health
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Amarantus Bioscience Holdings Inc. stock logo
AMBS
Amarantus Bioscience
N/AN/AN/AN/AN/AN/AN/AN/AN/A
ARHCF
Alfresa
N/AN/AN/AN/AN/AN/AN/AN/AN/A
CHCR
Advanzeon Solutions
N/AN/AN/AN/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Aeon Global Health Corp stock logo
AGHC
Aeon Global Health
N/AN/AN/AN/AN/A
Amarantus Bioscience Holdings Inc. stock logo
AMBS
Amarantus Bioscience
N/AN/AN/AN/AN/A
ARHCF
Alfresa
N/AN/AN/AN/AN/A
CHCR
Advanzeon Solutions
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Aeon Global Health Corp stock logo
AGHC
Aeon Global Health
N/A
Amarantus Bioscience Holdings Inc. stock logo
AMBS
Amarantus Bioscience
N/A
ARHCF
Alfresa
N/A
CHCR
Advanzeon Solutions
N/A

Insider Ownership

CompanyInsider Ownership
Aeon Global Health Corp stock logo
AGHC
Aeon Global Health
11.50%
Amarantus Bioscience Holdings Inc. stock logo
AMBS
Amarantus Bioscience
10.33%
ARHCF
Alfresa
N/A
CHCR
Advanzeon Solutions
16.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aeon Global Health Corp stock logo
AGHC
Aeon Global Health
52N/AN/ANot Optionable
Amarantus Bioscience Holdings Inc. stock logo
AMBS
Amarantus Bioscience
12N/AN/ANot Optionable
ARHCF
Alfresa
12,525N/AN/ANot Optionable
CHCR
Advanzeon Solutions
2N/AN/ANot Optionable

Recent News About These Companies

Adapt faster. Work smarter. Perform better.
September 9, 2024  |  microsoft.comhttps://www.microsoft.com/en-us/dynamics-365/solutions/erp
WWF supports the implementation of urban nature-based solutions for nature and people.
August 14, 2023  |  wwf.panda.orgW
Advanzeon Solutions Inc (CHCR)
January 31, 2022  |  nasdaq.comhttps://www.nasdaq.com/market-activity/stocks/chcr/historical-nocp?random=61f53b6fe6200
Advanzeon Solutions, Inc. (CHCR)
October 10, 2021  |  ca.finance.yahoo.comhttps://ca.finance.yahoo.com/quote/CHCR/analysis/

Media Sentiment Over Time

Aeon Global Health stock logo

Aeon Global Health OTCMKTS:AGHC

AEON Global Health Corp. is a growth oriented provider of personalized, actionable medical informatics, and telemedicine. It offers a comprehensive menu of diagnostic and laboratory developed assays, as well as interpretive data for a range of inherited conditions. The company was founded by Hanif A. Roshan and Shawn Desai in August 1985 and is headquartered in Gainesville, GA.

Amarantus Bioscience stock logo

Amarantus Bioscience OTCMKTS:AMBS

Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. The company's diagnostic products in development include the lymphocyte proliferation (LymPro) test, a diagnostic blood test for Alzheimer's disease; and MSPrecise, a proprietary DNA sequencing assay for the identification of patients with multiple sclerosis. Its therapeutic products in development comprise Eltoprazine, a small molecule drug for the treatment of Parkinson's disease Levadopa-Induced Dyskinesia and attention deficit hyperactivity disorders; and mesencephalic-astrocyte-derived neurotrophic factor for the treatment of various animal models, including retinitis pigmentosa and retinal artery occlusion. It also develops NuroPro, a neurodegenerative disease diagnostic platform with application in Parkinson's disease; BC-SeraPro, an oncology diagnostic platform with application in breast cancer; and PhenoGuard platform for neurrotrophic factor discovery. In addition, the company develops Engineered Skin Substitute (ESS), a cell therapy-based autologous skin replacement product that is in mid-stage clinical development for the treatment of life-threatening severe burns. Amarantus BioScience Holdings, Inc. has a cooperative research and development agreement with the U.S. Army Institute of Surgical Research and Rutgers University. The company was formerly known as Amarantus Bioscience, Inc. and changed its name to Amarantus BioScience Holdings, Inc. in April 2013. Amarantus BioScience Holdings, Inc. was founded in 2008 and is headquartered in New York, New York.

Alfresa OTCMKTS:ARHCF

$14.00 0.00 (0.00%)
As of 10/6/2026

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related businesses. The company was incorporated in 2003 and is based in Tokyo, Japan.

Advanzeon Solutions OTCMKTS:CHCR

Advanzeon Solutions, Inc., through its subsidiary, Pharmacy Value Management Solutions, Inc., administers and operates a sleep apnea program known as SleepMaster Solutions. The company was formerly known as Comprehensive Care Corporation and changed its name to Advanzeon Solutions, Inc. in January 2014. Advanzeon Solutions, Inc. was founded in 1969 and is headquartered in Tampa, Florida. On September 8, 2022, the voluntary petition of Advanzeon Solutions, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on September 7, 2020.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas